ID   FMO3_RAT                Reviewed;         531 AA.
AC   Q9EQ76; Q5PQV6;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   24-JUL-2024, entry version 139.
DE   RecName: Full=Flavin-containing monooxygenase 3 {ECO:0000250|UniProtKB:P31513};
DE            EC=1.14.13.148 {ECO:0000250|UniProtKB:P31513};
DE            EC=1.14.13.32 {ECO:0000269|PubMed:3739217, ECO:0000269|PubMed:7736906};
DE            EC=1.14.13.8 {ECO:0000250|UniProtKB:P31513};
DE   AltName: Full=Dimethylaniline monooxygenase [N-oxide-forming] 3;
DE   AltName: Full=Dimethylaniline oxidase 3;
DE   AltName: Full=Hepatic flavin-containing monooxygenase 3;
DE            Short=FMO 3;
DE   AltName: Full=Trimethylamine monooxygenase;
GN   Name=Fmo3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11414682; DOI=10.1006/abbi.2001.2317;
RA   Lattard V., Buronfosse T., Lachuer J., Longin-Sauvageon C., Moulin C.,
RA   Benoit E.;
RT   "Cloning, sequencing, tissue distribution, and heterologous expression of
RT   rat flavin-containing monooxygenase 3.";
RL   Arch. Biochem. Biophys. 391:30-40(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=3739217; DOI=10.1007/bf02213995;
RA   Fargetton X., Galtier P., Delatour P.;
RT   "Sulfoxidation of albendazole by a cytochrome P450-independent
RT   monooxygenase from rat liver microsomes.";
RL   Vet. Res. Commun. 10:317-324(1986).
RN   [4]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=7736906;
RA   Moroni P., Buronfosse T., Longin-Sauvageon C., Delatour P., Benoit E.;
RT   "Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-
RT   containing and cytochrome P450-dependent monooxygenases from rat liver
RT   microsomes.";
RL   Drug Metab. Dispos. 23:160-165(1995).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19307449; DOI=10.1124/jpet.109.152058;
RA   Novick R.M., Mitzey A.M., Brownfield M.S., Elfarra A.A.;
RT   "Differential localization of flavin-containing monooxygenase (FMO)
RT   isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of
RT   FMO4 in mouse, rat, and human liver and kidney microsomes.";
RL   J. Pharmacol. Exp. Ther. 329:1148-1155(2009).
CC   -!- FUNCTION: Essential hepatic enzyme that catalyzes the oxygenation of a
CC       wide variety of nitrogen- and sulfur-containing compounds including
CC       drugs as well as dietary compounds (PubMed:3739217, PubMed:7736906).
CC       Plays an important role in the metabolism of trimethylamine (TMA), via
CC       the production of trimethylamine N-oxide (TMAO) metabolite. TMA is
CC       generated by the action of gut microbiota using dietary precursors such
CC       as choline, choline containing compounds, betaine or L-carnitine. By
CC       regulating TMAO concentration, FMO3 directly impacts both platelet
CC       responsiveness and rate of thrombus formation.
CC       {ECO:0000250|UniProtKB:P31513, ECO:0000269|PubMed:3739217,
CC       ECO:0000269|PubMed:7736906}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADPH + O2 + trimethylamine = H2O + NADP(+) + trimethylamine
CC         N-oxide; Xref=Rhea:RHEA:31979, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15724, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:58389; EC=1.14.13.148;
CC         Evidence={ECO:0000250|UniProtKB:P31513};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31980;
CC         Evidence={ECO:0000250|UniProtKB:P31513};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + N,N-dimethylaniline + NADPH + O2 = H2O + N,N-
CC         dimethylaniline N-oxide + NADP(+); Xref=Rhea:RHEA:24468,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16269, ChEBI:CHEBI:17735, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.14.13.8;
CC         Evidence={ECO:0000250|UniProtKB:P31513};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24469;
CC         Evidence={ECO:0000250|UniProtKB:P31513};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hypotaurine + NADPH + O2 = H2O + NADP(+) + taurine;
CC         Xref=Rhea:RHEA:69819, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:57783, ChEBI:CHEBI:57853,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:507393; EC=1.14.13.8;
CC         Evidence={ECO:0000250|UniProtKB:P31513};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69820;
CC         Evidence={ECO:0000250|UniProtKB:P31513};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-nicotine + NADPH + O2 = H2O + NADP(+) + trans-(S)-nicotine
CC         N(1')-oxide; Xref=Rhea:RHEA:58720, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:59806, ChEBI:CHEBI:142660;
CC         Evidence={ECO:0000250|UniProtKB:P31513};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58721;
CC         Evidence={ECO:0000250|UniProtKB:P31513};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=albendazole + H(+) + NADPH + O2 = albendazole S-oxide + H2O +
CC         NADP(+); Xref=Rhea:RHEA:10796, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16664, ChEBI:CHEBI:16959,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.14.13.32;
CC         Evidence={ECO:0000269|PubMed:3739217, ECO:0000269|PubMed:7736906};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10797;
CC         Evidence={ECO:0000305|PubMed:3739217};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:19307449};
CC       Single-pass membrane protein {ECO:0000255}. Endoplasmic reticulum
CC       membrane {ECO:0000250|UniProtKB:P32417}; Single-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Detected in liver and kidney (at protein level)
CC       (PubMed:19307449). Expressed in kidney and liver. Weakly expressed in
CC       lung. Does not seem to be expressed in brain, adipose tissue, or
CC       muscle. {ECO:0000269|PubMed:11414682, ECO:0000269|PubMed:19307449}.
CC   -!- SIMILARITY: Belongs to the FMO family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF286595; AAG44891.1; -; mRNA.
DR   EMBL; BC087008; AAH87008.1; -; mRNA.
DR   RefSeq; NP_445885.2; NM_053433.2.
DR   AlphaFoldDB; Q9EQ76; -.
DR   SMR; Q9EQ76; -.
DR   IntAct; Q9EQ76; 1.
DR   STRING; 10116.ENSRNOP00000004864; -.
DR   CarbonylDB; Q9EQ76; -.
DR   iPTMnet; Q9EQ76; -.
DR   PhosphoSitePlus; Q9EQ76; -.
DR   PaxDb; 10116-ENSRNOP00000004864; -.
DR   GeneID; 84493; -.
DR   KEGG; rno:84493; -.
DR   UCSC; RGD:619761; rat.
DR   AGR; RGD:619761; -.
DR   CTD; 2328; -.
DR   RGD; 619761; Fmo3.
DR   eggNOG; KOG1399; Eukaryota.
DR   InParanoid; Q9EQ76; -.
DR   OrthoDB; 2079054at2759; -.
DR   PhylomeDB; Q9EQ76; -.
DR   TreeFam; TF105285; -.
DR   BRENDA; 1.14.13.8; 5301.
DR   Reactome; R-RNO-217271; FMO oxidises nucleophiles.
DR   SABIO-RK; Q9EQ76; -.
DR   PRO; PR:Q9EQ76; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0047638; F:albendazole monooxygenase activity; IEA:RHEA.
DR   GO; GO:0016597; F:amino acid binding; IPI:RGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0047822; F:hypotaurine dehydrogenase activity; ISO:RGD.
DR   GO; GO:0004497; F:monooxygenase activity; TAS:RGD.
DR   GO; GO:0004499; F:N,N-dimethylaniline monooxygenase activity; IDA:RGD.
DR   GO; GO:0050661; F:NADP binding; IPI:RGD.
DR   GO; GO:0034899; F:trimethylamine monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042412; P:taurine biosynthetic process; ISO:RGD.
DR   GO; GO:0006805; P:xenobiotic metabolic process; IDA:RGD.
DR   Gene3D; 3.50.50.60; FAD/NAD(P)-binding domain; 3.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR000960; Flavin_mOase.
DR   InterPro; IPR020946; Flavin_mOase-like.
DR   InterPro; IPR002255; Flavin_mOase_3.
DR   InterPro; IPR050346; FMO.
DR   PANTHER; PTHR23023; DIMETHYLANILINE MONOOXYGENASE; 1.
DR   PANTHER; PTHR23023:SF44; DIMETHYLANILINE MONOOXYGENASE [N-OXIDE-FORMING] 3; 1.
DR   Pfam; PF00743; FMO-like; 1.
DR   PIRSF; PIRSF000332; FMO; 1.
DR   PRINTS; PR00370; FMOXYGENASE.
DR   PRINTS; PR01123; FMOXYGENASE3.
DR   SUPFAM; SSF51905; FAD/NAD(P)-binding domain; 2.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; FAD; Flavoprotein; Membrane; Microsome;
KW   Monooxygenase; NADP; Oxidoreductase; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..531
FT                   /note="Flavin-containing monooxygenase 3"
FT                   /id="PRO_0000147659"
FT   TRANSMEM        511..531
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   BINDING         9..13
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         32
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         40..41
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         60..61
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         61..62
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         195..198
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   MOD_RES         401
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97501"
FT   CONFLICT        501
FT                   /note="V -> D (in Ref. 2; AAH87008)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   531 AA;  59960 MW;  35A89988323B311F CRC64;
     MKRKVAVIGA GVSGLAAIRS CLEEGLEPTC FERSDDVGGL WKFSDHTEEG RASIYQSVFT
     NSSKEMMCFP DFPYPDDFPN FMHNSKLQEY ITSFATEKNL LKYIQFETLV TRINKCPDFS
     TTGKWEVTTE KNSKKETAVF DAVMICSGHH VYPHLPKDSF PGLNRFKGKC FHSRDYKEPG
     TWKGKRVLVI GLGNSGCDIA AELSHVAQQV IISSRSGSWV MSRVWNDGYP WDMVVITRFQ
     TFLKNNLPTA ISDWWYMKQM NARFKHENYG LMPLNGTLRK EPVFNDELPA RILCGTVSIK
     PNVKEFTETS AVFEDGTVFE GIDCVIFATG YGYAYPFLDD SIIKSRNNEV TLYKGIFPPQ
     LEKPTMAVIG LVQSLGAAIP TTDLQARWAA QVIRGTCILP SVNDMMDDID EKMGKKLKWF
     GNSTTIQTDY IVYMDELASF IGAKPNILWL FLKDPRLAIE VFFGPCSPYQ FRLVGPGKWS
     GARNAILTQW DRSLKPMKTR VVGGIQKPCL YSHFLRLLAV PVLIALFLVL I
//
